Katia M Perez1, Emily R Hamburger2, Morgan Lyttle2, Rodayne Williams2, Erin Bergner2, Sachini Kahanda2, Erin Cobry2, Sarah S Jaser3. 1. Wake Forest School of Medicine, Winston-Salem, NC, USA. 2. Vanderbilt University Medical Center, Village at Vanderbilt, 1500 21st Ave. South, Suite 1514, Nashville, TN, 37212, USA. 3. Vanderbilt University Medical Center, Village at Vanderbilt, 1500 21st Ave. South, Suite 1514, Nashville, TN, 37212, USA. sarah.jaser@vanderbilt.edu.
Abstract
PURPOSE OF REVIEW: To highlight recent findings from studies of sleep in type 1 diabetes (T1D), with a focus on the role of sleep in self-management, the cognitive and psychosocial outcomes related to sleep disturbances, and factors associated with sleep disturbances specific to T1D. RECENT FINDINGS: People with T1D experience higher rates of sleep disturbances than people without diabetes, and these disturbances have negative implications for glycemic control and diabetes management, as well as psychosocial and cognitive outcomes. Inconsistent sleep timing (bedtime and wake time) has emerged as a potential target for interventions, as variability in sleep timing has been linked with poorer glycemic control and adherence to treatment. Sleep-promoting interventions and new diabetes technology have the potential to improve sleep in people with T1D. Sleep is increasingly considered a critical factor in diabetes management, but more multi-method and longitudinal research is needed. We emphasize the importance of sufficient and consistent sleep for people with T1D, and the need for providers to routinely assess sleep among patients with T1D.
PURPOSE OF REVIEW: To highlight recent findings from studies of sleep in type 1 diabetes (T1D), with a focus on the role of sleep in self-management, the cognitive and psychosocial outcomes related to sleep disturbances, and factors associated with sleep disturbances specific to T1D. RECENT FINDINGS:People with T1D experience higher rates of sleep disturbances than people without diabetes, and these disturbances have negative implications for glycemic control and diabetes management, as well as psychosocial and cognitive outcomes. Inconsistent sleep timing (bedtime and wake time) has emerged as a potential target for interventions, as variability in sleep timing has been linked with poorer glycemic control and adherence to treatment. Sleep-promoting interventions and new diabetes technology have the potential to improve sleep in people with T1D. Sleep is increasingly considered a critical factor in diabetes management, but more multi-method and longitudinal research is needed. We emphasize the importance of sufficient and consistent sleep for people with T1D, and the need for providers to routinely assess sleep among patients with T1D.
Authors: Z Landau; M Rachmiel; O Pinhas-Hamiel; M Boaz; Y Bar-Dayan; J Wainstein; R Tauman Journal: Acta Diabetol Date: 2013-12-27 Impact factor: 4.280
Authors: Nathaniel F Watson; M Safwan Badr; Gregory Belenky; Donald L Bliwise; Orfeu M Buxton; Daniel Buysse; David F Dinges; James Gangwisch; Michael A Grandner; Clete Kushida; Raman K Malhotra; Jennifer L Martin; Sanjay R Patel; Stuart F Quan; Esra Tasali Journal: Sleep Date: 2015-06-01 Impact factor: 5.849
Authors: Trang T Ly; Stuart A Weinzimer; David M Maahs; Jennifer L Sherr; Anirban Roy; Benyamin Grosman; Martin Cantwell; Natalie Kurtz; Lori Carria; Laurel Messer; Rie von Eyben; Bruce A Buckingham Journal: Pediatr Diabetes Date: 2016-05-18 Impact factor: 4.866
Authors: Sarah S Jaser; Emily R Hamburger; Erin M Bergner; Rodayne Williams; James C Slaughter; Jill H Simmons; Beth A Malow Journal: Pediatr Diabetes Date: 2020-02-11 Impact factor: 4.866